NVAX logo

NVAX
Novavax Inc

107,869
Mkt Cap
$1.7B
Volume
3.47M
52W High
$11.97
52W Low
$6.13
PE Ratio
-17.27
NVAX Fundamentals
Price
$11.07
Prev Close
$10.32
Open
$10.27
50D MA
$8.83
Beta
1.48
Avg. Volume
3M
EPS (Annual)
$2.54
P/B
-11.72
Rev/Employee
$1.5M
$695.34
Loading...
Loading...
News
all
press releases
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks
News Placeholder
More News
News Placeholder
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks
News Placeholder
Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone?
Key PointsModerna, Novavax, and Inovio have all seen their stocks surge due to concerns about hantavirus...
Nasdaq News: Markets
News Placeholder
MRNA, INO, SABS, NVAX Stocks Jump Premarket: Deadly Hantavirus Reaches US After Cruise Ship Outbreak
The HHS confirmed that one American passenger evacuated from the MV Hondius cruise ship tested mildly positive for the Andes strain of hantavirus.
Stocktwits
News Placeholder
What's Going On With Novavax Stock On Friday?
Moderna is researching hantavirus vaccine with U.S. Army while Novavax stock rises due to increased public health threatread more...
Benzinga
News Placeholder
INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally
Inovio is the most direct hantavirus play based on earlier DNA vaccine studies targeting Andes, Hantaan, and Puumala strains.
Stocktwits
News Placeholder
Novavax to Participate in BofA Securities 2026 Health Care Conference
Novavax to Participate in BofA Securities 2026 Health Care Conference Novavax to Participate in BofA Securities 2026 Health Care Conference PR Newswire GAITHERSBURG, Md., May 7, 2026 GAITHERSBURG...
PR Newswire
News Placeholder
NVAX Q1 Earnings Beat, Stock Jumps 16% on Matrix-M Deal Momentum
Novavax's shares rise 16% after Q1 earnings beat estimates as the company expands Matrix-M partnerships across oncology and infectious diseases.
Zacks
News Placeholder
Company News for May 7, 2026
Companies in The News Are: DIS,NVAX,MAR,BWA
Zacks
News Placeholder
NVAX Stock Eyes Breakout Week: Novavax Claims Patients Were ‘Twice As Likely’ To Pick Its COVID Shot Over Moderna Again
The company spotlighted new data showing that its COVID vaccine, Nuvaxovid, produced “statistically fewer side effects” than Moderna’s mNEXSPIKE vaccine.
Stocktwits
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available